In February 2023, Boston Scientific received FDA 510(k) clearance for its LithoVue Elite Single-Use Digital Flexible Ureteroscope System. This innovative device is the first ureteroscope system equipped with real-time intrarenal pressure monitoring, enabling urologists to make informed decisions during kidney stone procedures. The system features enhanced image quality through a high-resolution digital chip and advanced imaging software, providing sharper visuals and greater depth of field. In addition, the StoneSmart Connect Console allows seamless integration with existing operating room equipment, reducing clutter and capital footprint. By offering improved procedural efficiency and patient safety, the LithoVue Elite System is poised to significantly impact the urology market, addressing the growing demand for advanced, single-use endoscopic solutions
